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Michael Sonntag*, Hans-Helmut König and Alexander KonnopkaAbstract
Objective: To compare the responsiveness of the EQ-5D index (German and British tariff), the EQ-5D visual
analogue scale (EQ VAS), and time trade-off (TTO) scores in schizophrenia, affective disorders, and alcohol addiction.
Methods: We used a sample of 502 patients and examined the measures at baseline and after 14 months. We
used the generic “WHO Quality of Life BREF” (WHOQOL) and the disorder-specific “Global Severity Index” (GSI) as
anchors for a relevant improvement in a patient’s health status. In a complete case analysis, we assessed the
responsiveness, which is the ability to detect a change given a relevant change on the anchor. We computed the
effect sizes (ESs) and standardised response means (SRMs).
Results: In patients with schizophrenia, the ESs and SRMs were large (ES/SRM > 0.8) for the British EQ-5D index
(ESGSI: 0.93; SRMGSI: 0.89; SRMWHOQOL: 0.82). In patients with affective disorders, we found large ESs and SRMs for the
EQ VAS (ESGSI: 1.79; ESWHOQOL: 0.90; SRMGSI: 1.52; SRMWHOQOL: 0.93) and a large ES for the British EQ-5D index (ESGSI:
0.88). In patients with alcohol addiction, the ESs and SRMs were large for the EQ VAS (ESGSI: 1.40; ESWHOQOL: 0.94;
SRMGSI: 1.04; SRMWHOQOL: 0.83). The ESs and SRMs of the German EQ-5D index were consistently lower than those
of the British EQ-5D index. Regarding TTO score, ESs and SRMs were generally less than 0.5.
Conclusions: No preference-based instrument was consistently more responsive than others across all mental
disorders. While the EQ VAS was the most responsive instrument in patients with affective disorders or alcohol
addiction, the British EQ-5D index was reasonably responsive in patients with schizophrenia.
Keywords: Responsiveness, Schizophrenia, Affective disorders, Alcohol addiction, EQ-5D, TTOIntroduction
Various approaches and instruments can be used to assess
patients’ health related quality of life (HRQOL). In the field
of economic evaluation, preference-based instruments are
often used to assess HRQOL. These instruments quantify a
preference-based valuation of the patient’s current health
state by so-called utility weights, which usually range from
0 (death) to 1 (full health) and should be comparable across
diseases and disorders. Preference-based instruments can
be categorised into direct and indirect instruments [1, 2]. In
direct instruments, patients value their own experienced
health state or described vignettes directly. Common direct* Correspondence: mi.sonntag@uke.de
Department of Health Economics and Health Services Research, Hamburg
Center for Health Economics, University Medical Center Hamburg-Eppendorf,
Martinistr. 52, 20246 Hamburg, Germany
© 2015 Sonntag et al. This is an Open Access
(http://creativecommons.org/licenses/by/4.0),
provided the original work is properly credited
creativecommons.org/publicdomain/zero/1.0/instruments are the time trade-off (TTO) or standard gam-
ble. In indirect instruments, there are two steps to assess
utility weights: first, persons of a reference population value
a set of predefined generic or condition-specific health
states via direct instruments. Based on these valuations, an
algorithm is generated to estimate utility weights for each
possible health state of the indirect instrument. Second, pa-
tients describe their health state on the indirect instrument,
and the corresponding utility weight is assigned to the
reported health state. Common indirect instruments in
patients with mental disorders are the EQ-5D and the SF-
6D [3].
Before a preference-based instrument is used in eco-
nomic evaluations, its psychometric properties should be
tested. An important psychometric property is respon-
siveness, which refers to an instrument’s ability to detectarticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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over time [4].
Although some studies have already compared the re-
sponsiveness of various preference-based instruments
[5–10], only a few studies have compared the respon-
siveness of preference-based instruments in patients
with mental disorders [11–14]. In patients with mental
disorders, however, no study has compared the respon-
siveness of direct and indirect preference-based instru-
ments. Thus, the purpose of this study was to compare
the responsiveness of the EQ-5D index (British and
German tariff ), the EQ-5D visual analogue scale (EQ
VAS), and the TTO score in patients with schizophrenia,
affective disorders, or alcohol addiction.
Methods
Subjects and study design
The data of this study came from a study that analysed a
new financing model for mental health care in two re-
gions of Northern Germany [15]. The study sample con-
sisted of 170 patients with schizophrenic, schizotypal, or
delusional disorders (ICD-10: F2) [16]; 171 patients with
affective disorders (ICD-10: F3); and 161 patients with
alcohol addiction (ICD-10: F10). The patients were re-
cruited from September 2003 to March 2004 in in-
patient, day clinic, or outpatient settings. Five hundred




The EQ-5D measures HRQOL by three concepts [17]:
(I) the patient-reported “EQ-5D descriptive system” has
five dimensions (“mobility”, “self-care”, “usual activities”,
“pain/discomfort”, and “anxiety/depression”) with three
ordinal levels (“no problems”, “moderate problems”, and
“severe problems”), resulting in 243 (35) possible health
states.
(II) A utility weight (EQ-5D index) can be attached to
the answers on the EQ-5D descriptive system according
to a country-specific tariff. The utility weight is based on
the valuation of health states by the general population,
which represents the value of a patient’s health state
from a general population’s perspective. The EQ-5D
index score ranges from health states that are valued
worse than death to death (0) to full health (1). The
value of the worst possible health state is −0.59 on the
British EQ-5D index (EQ-5D index-UK) [18] and −0.21
on the German EQ-5D index (EQ-5D index-G) [19].
Despite the analysis being of a German patient sample,
we used both EQ-5D indexes because the estimation of
the EQ-5D index-G was based on a rather small sample
(nGerman = 334 vs. nUK = 2997) and on the valuation of
fewer health states (36 vs. 43). Because most of thevalued health states had large standard deviations in re-
lation to the mean in the German sample, a regression
model without non-significant variables was computed.
Based on the study’s results, the EQ-5D index-G score
does not change if the patients have improved from level
2 (“moderate problems”) to level 1 (“no problems”) in
the dimension “anxiety/depression”. Thus, the EQ-5D
index-G scores must be considered as less precise.
(III) Respondents rate their current health state on the
EQ VAS, which is a rating scale similar to a thermometer
that ranges from 0 (worst imaginable health state) to
100 (best imaginable health state). The EQ VAS repre-
sents the value of HRQOL from the respondent’s per-
spective. Based on economic theory, the EQ VAS does
not represent choice-based preferences and thus pro-
duces no utility weights [20–22]. However, the EQ VAS
has been shown to explain a substantial proportion of
the variance in standard gamble and TTO [23]. Despite
these theoretical limitations, we labelled the EQ VAS as
a preference-based instrument. To better compare the
preference-based instruments, we divided the EQ VAS
score by 100.
TTO
The TTO assessment was based as closely as possible on
the protocol of the Measurement and Valuation of
Health (MVH) Group [24] (see TTO study protocol in
the Additional file 1). Accordingly, patients had to
choose between two hypothetical alternatives in personal
interviews: in the first alternative, patients stayed in their
current health state for 10 years followed by death; in
the second alternative, patients stayed x years at full
health followed by death (restricted to x ≤ 10 years).
Time x was varied until the patient was indifferent be-
tween the two alternatives, leading to a utility weight of
“x/10”. If the patient preferred zero years at full health
(which equals immediate death) to 10 years in the
current health state, the patient valued their current
health state worse than death. In this case, utility weights
can be negatively infinite for health states valued worse
than death.
WHOQOL-BREF
The WHOQOL-BREF is a self-administered generic
HRQOL measure referring to the previous two weeks. It
is a short version of the WHOQOL-100 measure and
contains 26 items, each rated on a 5-point Likert scale.
Two items assess the patients’ overall perception of
quality of life and their health, respectively. The other 24
items can be summarised in a global score. The global
score ranges from 0 (worst) to 100 (best). It has been
shown that the WHOQOL-BREF is valid, reliable, and
responsive in patients with schizophrenia, affective dis-
orders, or alcohol addiction [25–27].
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The SCL-90R is a self-administered questionnaire meas-
uring the distress induced by mental symptoms in the
previous 7 days [28]. Each of the 90 items ranges from 0
(best) to 4 (worst). The items can be aggregated to the
Global Severity Index (GSI), which represents the mean
of all the item scores ranging from 0 (best) to 4 (worst).Analysis
We only analysed the responsiveness in patients with an
improved health status because the number of patients
with a deteriorated health status was very small. We
conducted a complete case analysis regarding the
preference-based instruments. We used both the GSI
and WHOQOL-BREF global scores as anchors to iden-
tify patients with an improved health status. Because of
the lack of available minimal important differences in
the anchors, a relevant health status change on the an-
chor was defined as more than ±0.5 standard deviations
(baseline) for each mental disorder [29, 30].
In regard to the TTO, 15 patients had utility weights
less than −1.00 (lowest TTO score: −19) at baseline. Be-
cause outliers strongly influence the coefficients of the
ES and SRM in small sample sizes, we censored the
range of the TTO from −1.00 to 1.00.
We assessed the correlation between the preference-
based instruments and each anchor to ensure that the
constructs of both instruments were similar. We com-
puted Spearman’s rank correlation coefficient because
the preference-based instruments did not follow a nor-
mal distribution. According to Cohen, we defined a cor-
relation coefficient as small if 0.1 ≤ |rs| < 0.3, moderate if
0.3 ≤ |rs| < 0.5, and large if |rs| ≥ 0.5 [31].
Responsiveness can be assessed in various ways
[32–35]. In our analysis, we computed effect sizes
(ESs, mean of change scores divided by the standard
deviation at baseline) and standardised response
means (SRMs, mean of change scores divided by the
standard deviation of the change scores) of each
preference-based instrument given a relevant improve-
ment on the anchor. Both responsiveness scores pro-
vide information on the magnitude of change in
relation to the level of variation at baseline (ES) or in
relation to the level of variation in change scores
(SRM). Thus, the interpretation of responsiveness dif-
fers between ES and SRM according to how the level
of variation is defined. According to Cohen [31], we
defined the scores of ES and SRM as trivial from ≥
|0.1| to < |0.2|, as small from ≥ |0.2| to < |0.5|, as
medium from ≥ |0.5| to < |0.8|, and as large if ≥ |0.8|.
The statistical analyses were conducted using the Stat-
istical Package for the Social Sciences (version 18, SPSS
Inc., Chicago, IL, USA).Results
Patient characteristics
The patient characteristics at baseline are shown in
Table 1. Most of the schizophrenic patients were male
(57.6 %), unmarried (61.2 %), and lived alone (33.7 %).
The patients with affective disorders were mostly female
(69.0 %), married (37.4 %), and lived with their spouse/
partner (48.8 %). Most of the patients with alcohol
addiction were male (71.4 %), separated/divorced
(36.6 %), and lived alone (50.9 %). Across all disorders,
most patients had a lower secondary school degree.
Score distribution at baseline
Scores of instruments used as anchors
The patients with schizophrenia showed the highest mean
WHOQOL-BREF score (57.4) and the lowest mean GSI
score (0.62; Table 2). The patients with affective disorders
reported the lowest mean WHOQOL-BREF score (44.8)
and the highest mean GSI score (0.95). In the patients
with alcohol addiction, the mean WHOQOL-BREF score
was 49.4 (SD: 21.7) and the mean GSI score was 0.65
(SD: 0.60), indicating moderate psychopathological
problems.
Scores of preference-based instruments
Across all disorders, the mean EQ-5D index-G score
was the highest, followed by the TTO, EQ-5D index-UK,
and EQ VAS scores, except in the patients with alcohol
addiction for whom the mean EQ-5D index-UK score
(0.710) was higher than the mean TTO score (0.650,
Table 2). No preference-based instrument showed floor
effects at baseline (results not shown). Both EQ-5D in-
dexes and TTO showed ceiling effects in contrast to the
EQ VAS (<5 %). In the patients with schizophrenia, 25 %
(measured by the EQ-5D index-UK), 43 % (EQ-5D
index-G), and 45 % (TTO) of all patients reported full
health. In the patients with affective disorders, 15 %
(EQ-5D index-UK) and 34 % (EQ-5D index-G/TTO) of
all patients reported full health. In the patients with al-
cohol addiction, 10 % (EQ-5D index-UK), 31 % (EQ-5D
index-G), and 26 % (TTO) of all patients reported full
health.
Comparing the means of the patient population with
those of the German population norms, the available
means of the German population norms were consist-
ently higher than the means of each patient group.
Correlation between scores of the preference-based
instruments and scores of the anchors
Across all disorders, we mostly found moderate Spear-
man’s rank correlation coefficients between the EQ-5D
index-G/TTO scores and the WHOQOL-BREF/GSI
scores. The EQ-5D index-UK scores and the EQ VAS









N 170 171 161
Gender: n (%)
Male 98 (57.6) 53 (31.0) 115 (71.4)
Female 72 (42.4) 118 (69.0) 46 (28.6)
Family status:
n (%)
Unmarried 104 (61.2) 49 (28.7) 42 (26.1)
Married 31 (18.2) 64 (37.4) 47 (29.2)
Separated/
divorced
29 (17.1) 38 (22.2) 59 (36.6)
Widowed 6 (3.5) 20 (11.7) 13 (8.1)
Living situation:
n (%)
Alone 57 (33.7) 65 (38.3) 82 (50.9)
With spouse/
partner
41 (24.3) 83 (48.8) 68 (42.2)
Nursing
home
42 (24.8) 7 (4.1) 4 (2.5)
Other forms 29 (17.2) 15 (8.8) 7 (4.4)
Education:
n (%)
Low 79 (46.4) 79 (46.5) 91 (56.9)
Middle 53 (31.2) 61 (35.9) 47 (29.4)
High 36 (21.2) 29 (17.1) 18 (11.2)
Other 2 (1.2) 1 (0.5) 4 (2.5)
Age: mean (SD) 41.0 (10.9) 48.3 (15.5) 47.8 (11.0)
Italics: percentage of the item; SD: standard deviation
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the scores of both anchors (Table 3).
Responsiveness
British EQ-5D index
In the patients with schizophrenia, there were large ESs
and SRMs on the EQ-5D index-UK (ESGSI: 0.93;
SRMGSI: 0.89; SRMWHOQOL-BREF: 0.82). In the patients
with affective disorders, there was a large ES (ESGSI:
0.88) anchored by the GSI (Table 4). In the patients with
alcohol addiction, the ESs and SRMs that were anchored
by the WHOQOL-BREF were small, whereas those
anchored by the GSI were medium (ESGSI: 0.64; SRMGSI:
0.56).
German EQ-5D index
In the patients with schizophrenia, the ESs and SRMs on
the EQ-5D index-G were medium (ESWHOQOL-BREF:
0.54; ESGSI: 0.66; SRMWHOQOL-BREF: 0.63; SRMGSI: 0.63).
In the patients with affective disorders or alcohol addic-
tion, the ESs and SRMs were generally small.EQ VAS
In the patients with schizophrenia, we found medium
ESs and SRMs (ESWHOQOL-BREF: 0.61; ESGSI: 0.58;
SRMWHOQOL-BREF: 0.70; SRMGSI: 0.63) on the EQ VAS.
In the patients with affective disorders, we found large
ESs and SRMs (ESWHOQOL-BREF: 0.90; ESGSI: 1.79;
SRMWHOQOL-BREF: 0.93; SRMGSI: 1.52). In the patients
with alcohol addiction, the ESs and SRMs were large
(ESWHOQOL-BREF: 0.94; ESGSI: 1.40; SRMWHOQOL-BREF:
0.83; SRMGSI: 1.04).
TTO
In the patients with schizophrenia, we found small and
trivial ESs and SRMs on the TTO score. In the patients
with affective disorders, we found a medium ES and
SRM (ESGSI: 0.56; SRMGSI: 0.74) anchored by the GSI.
In the patients with alcohol addiction, the ESs and SRMs
were small or trivial.
Discussion
In this study, we analysed the responsiveness of the EQ-
5D index-UK, the EQ-5D index-G, the EQ VAS, and the
TTO score in patients with schizophrenia, affective dis-
orders, or alcohol addiction with an improved health
status according to the WHOQOL-BREF or GSI, which
were used as anchors. We computed the ES and SRM to
assess and compare the responsiveness of the four
preference-based instruments.
The correlation coefficients between the preference-
based instruments and the anchors were mainly moder-
ate and large, indicating that the preference-based in-
struments captured relevant aspects of HRQOL that
were covered in the anchors. Thus, the constructs of the
preference-based instruments were similar to the con-
structs of both anchors.
Using two anchors, in total, we computed 24 ESs/
SRMs (4 preference-based instruments *2 anchors *3
mental disorders). Of the 24 computed ESs/SRMs, we
found six large ESs and six large SRMs. With the large
ESs, the corresponding SRM was large in five compari-
sons and medium in one comparison and vice versa.
Thus, the level of responsiveness between ES and SRM
was consistent in five of the six comparisons, indicating
that both responsiveness statistics may lead to the same
level of responsiveness. However, this evidence does not
imply that only one of both responsiveness statistics is
sufficient to assess the level of responsiveness. Various
factors influence the level of responsiveness in each
method. Whereas the distribution of the baseline scores
influences the ES, the SRM is influenced by the distribu-
tion of change scores (particularly the change scores of
outliers) [35, 36]. Depending on the particular study
population, ES and SRM can differ according to their
level of responsiveness.







Schizophrenia Affective disorders Alcohol addiction German population normsb
Instruments Mean (SD) Range Mean (SD) Range Mean (SD) Range N Mean (SD) Range
EQ-5D
index-G
−0.21 – 1.00 106/101/72 .855 (.255) 0.11 – 1.00 .828 (.214) 0.11 – 1.00 .840 (.200) 0.03 – 1.00 3552 .938 (.126) −0.20 – 1.00
EQ-5D index-UK −0.59 – 1.00 .735 (.278) −0.18 – 1.00 .678 (.266) −0.18 – 1.00 .710 (.230) −0.15 – 1.00 3552 .908 (.166) −0.59
– 1.00
EQ VAS score (0 – 100) /100 .691 (.182) 0.2 – 1.00 .582 (.242) 0 – 1.00 .583 (.212) 0.02 – 1.00 3546 .774 (.193) 0 – 1.00
Time trade off −1.00 – 1.00 .810 (.310) −1.00 – 1.00 .700 (.380) −0.67 – 1.00 .650 (.370) −0.54
– 1.00
n.a.
WHOQOL-BREF 0 – 100 170/171/161 57.4 (21.0) 0 – 100 44.8 (24.1) 0 – 100 49.4 (21.7) 0 – 100 n.a.
GSI 4 – 0 146/140/147 0.62 (0.52) 2.64 – 0 0.95 (0.71) 3.17 – 0 0.65 (0.60) 3.52 – 0 n.a.
a Number of observations varied due to missing values; b data based on [42]; EQ-5D index-G/UK: German/British EQ-5D index; GSI: global severity index; n.a.: not available for the German population; SD: standard


















Table 3 Correlation between the EQ-5D scores, the time
trade-off scores and the scores of the anchors at baseline
Spearman rank correlation coefficient
Anchor Disorder n EQ-G EQ-UK EQ VAS TTO
WHOQOL-BREF F1 63 .234* .339* .635* .390*
F2 106 .469* .570* .472* .194*
F3 101 .381* .495* .758* .500*
GSI F1 72 -.171 -.345* -.356* -.345*
F2 88 -.622* -.744* -.469* -.281*
F3 82 -.465* -.649* -.736* -.397*
* p ≤ 0.05
EQ-G/UK: German/British EQ-5D index; F1: patients with alcohol addiction; F2:
patients with schizophrenia; F3: patients with affective disorders; GSI: global
severity index; TTO: time trade-off; VAS: visual analogue scale
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tion, the EQ VAS appeared to be the most responsive
instrument. This may be because of the different
characteristics of the EQ VAS and the EQ-5D index.
Compared to the EQ-5D index, the EQ VAS covers
all dimensions that the patients feel are subjectively
important in their HRQOL. In contrast, the EQ-5D
descriptive system predefines the HRQOL dimensions
that are externally considered important for patients’
HRQOL. Additionally, the EQ-5D descriptive system
only differentiates between three levels of severity. Pa-
tients may be reluctant to respond to an improvement in
the corresponding EQ-5D dimensions because the im-
provements may be considered marginal from the patient
perspective. In the EQ VAS, however, patients can re-
spond to these marginally perceived improvements with
small change scores. Therefore, the EQ VAS may encom-
pass more subjectively important HRQOL dimensions
than the EQ-5D index [37] and may even detect margin-
ally perceived improvements in patients’ HRQOL.
In patients with schizophrenia, the EQ-5D index-UK
appeared to be the most responsive instrument with
large ESs and SRMs despite large ceiling effects at base-
line. The EQ VAS had a lower level of responsiveness,Table 4 Responsiveness of the German and British EQ-5D index, EQ
status
Mean of change scores (SD baseline)
Anchor Disorder n EQ-G EQ-UK EQ VAS TTO
WHO QOL-BREF F1 46 .02 (.20) .06 (.23) .18 (.19) .10 (.38)
F2 46 .16 (.30) .23 (.34) .11 (.18) .09 (.39)
F3 54 .05 (.20) .12 (.25) .19 (.23) .13 (.42)
GSI F1 20 .09 (.22) .17 (.26) .26 (.19) .11 (.32)
F2 17 .20 (.29) .28 (.30) .10 (.18) .02 (.48)
F3 21 .11(.22) .22 (.25) .29 (.16) .25 (.45)
For clarity, we displayed only effect sizes (ES) and standardised response means (SR
EQ-G/UK: German/British EQ-5D index; F1: patients with alcohol addiction; F2: patie
index; SD: standard deviation; TTO: time trade-off; VAS: visual analogue scalewhich contrasts our previous argument that the EQ VAS
encompasses more subjectively important HRQOL di-
mensions than the EQ-5D index. A reason may be that
the descriptive system of the EQ-5D covers most of the
relevant HRQOL dimensions in this patient group. The
mean change score of the EQ-5D index-UK was higher
than those of the other preference-based instruments.
However, our results should be interpreted with caution
because previous studies showed that the responsiveness
of the (British and German) EQ-5D index was low in lar-
ger patient samples [13, 14, 38]. There may be two rea-
sons for the differences in the level of responsiveness.
The first reason may be our smaller sample size. The
second reason may be that the assessment of responsive-
ness differed from our study. Whereas Mulhern et al.
[14] assessed the responsiveness with SRM based on all
patients and no anchor, McCrone et al. [13] used the
SRM in relevantly improved patients based on a
disorder-specific anchor. Konnopka et al. [38] assessed
the responsiveness with the receiver operating character-
istic curve using other anchors (EQ-5D transition ques-
tion and a schizophrenia-specific measure). However, it
is difficult to decide whether an anchor is required at all
and if so, which anchor may be the most suitable (“gold
standard”) for the assessment of responsiveness (transi-
tion question, disease-specific, or generic anchor). When
using no anchor, the level of responsiveness is highly
depended on the particular treatment effects and is
based on “statistically significant” change, which may
not necessarily constitute a meaningful change in a pa-
tient’s health status [32]. However, the number of pa-
tients which can be used for the analysis is larger than
that if using anchor-based methods. In using an anchor,
the change in the preference-based instrument can be
linked to a meaningful change in the anchor. When
using transition questions, there is a definite indicator
for a change. However, if the transition question has
various levels (e.g., slightly, a little, a lot), it is unclear
which level of the change is meaningful for patients.VAS, and time trade-off scores for patients with improved health
Effect size Standardised response mean
EQ-G EQ-UK EQ VAS TTO EQ-G EQ-UK EQ VAS TTO
0.94 0.83
0.54 0.68 0.61 0.63 0.82 0.70
0.90 0.51 0.93
0.64 1.40 0.56 1.04
0.66 0.93 0.58 0.63 0.89 0.63
0.50 0.88 1.79 0.56 0.73 1.52 0.74
M) ≥ |0.5|. Large ESs and SRMs (ES/SRM ≥ |0.8|) were printed bold
nts with schizophrenia; F3: patients with affective disorders; GSI: global severity
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clinical changes in a patient’s health status, the question
is whether each marginal clinical change leads to a
change in the preference-based instrument. When using
a generic anchor, it is debateable whether the generic an-
chor is sensitive enough to detect meaningful health sta-
tus changes in the disease. Additionally, the assessment
of an anchor’s minimal important difference (MID) is in-
fluenced by the choice of the sample and the MID
method leading to different MIDs of the same anchor
[39, 40].
Both EQ-5D indexes are based on the same descriptive
system. In contrast to the EQ-5D index-UK, which had
two large ESs and SRMs, the EQ-5D index-G had no
large ESs or SRMs. The lower responsiveness of the EQ-
5D index-G may be a result of the instrument’s insensi-
tivity to a change from level 2 to level 1 in the EQ-5D
dimension “anxiety/depression”. It is expected that pa-
tients with mental disorders report the most changes in
this EQ-5D dimension.
To estimate the EQ-5D index scores, the TTO
method was used to value predefined health states of
the EQ-5D descriptive system. Thus, one may expect
that the TTO score and the EQ-5D index have a
similar level of responsiveness. In our study, we found
two large and two medium ESs and two large and
three medium SRMs in the EQ-5D index-UK. The
TTO score, however, had only one medium ES and
one medium SRM. This inconsistent level of respon-
siveness between the TTO score and the EQ-5D
index-UK may be based on two major reasons. First,
the TTO scores of our study referred to the valuation
of the patients’ own experienced and unrelated health
state, whereas the TTO scores used for the EQ-5D
index referred to the valuation of predefined and
hypothetical health states. Thus, the construct of the
valued health state is different between the TTO of
our study and the TTO used for the EQ-5D index.
Second, the TTO task may be more challenging for
patients than describing their current health state in
the EQ-5D descriptive system.
Studies comparing the responsiveness of preference-
based instruments in patients with mental disorders
We did not find any studies comparing the
preference-based instruments used in this study.
However, four studies compared the responsiveness of
the EQ-5D index-UK and the SF-6D in patients with
mental disorders. Gerhards and colleagues [11] com-
pared the responsiveness of the SF-6D and the EQ-
5D index-UK in patients with depression using the
ES and SRM. The ESs and SRMs ranged from small
to large and were anchored by a disease-specific in-
strument and a patient self-reported global rating ofchange. The SF-6D had slightly higher ESs and SRMs
than the EQ-5D index-UK. The authors concluded
that both instruments can be applied in assessing
health effects in patients with depression.
Lamers and colleagues [12] assessed the responsiveness
of the SF-6D and the EQ-5D index-UK in patients with
mood and/or anxiety disorders using the SRM. Without
using an anchor, the SRM of the SF-6D was consistently
higher (SRM ≈ 0.83) than the SRM of the EQ-5D index-
UK (SRM ≈ 0.46) in each severity subgroup.
McCrone and colleagues [13] compared the respon-
siveness of the EQ-5D index-UK with the SF-6D in pa-
tients with schizophrenia using the SRM. With an
improvement of the patients’ health status anchored by
a disease-specific instrument, the SRM of the EQ-5D
index-UK and the SF-6D were identical but small
(SRM= 0.39).
Mulhern and colleagues [14] assessed the responsive-
ness of the EQ-5D index-UK and the SF-6D in patients
with schizophrenia using the SRM. They included all pa-
tients who had completed both instruments at both time
points. Without referring to an anchor, the SRM of the
EQ-5D index-UK and the SF-6D were identical but triv-
ial (SRM = 0.12). In our study, however, we found that
the EQ-5D index-UK was reasonably responsive, irre-
spective of the responsiveness statistic.Strengths and limitations
This study was the first to compare the responsive-
ness of the EQ-5D index-UK, the EQ-5D index-G,
the EQ VAS, and the TTO score in patients with
schizophrenia, affective disorders, or alcohol addic-
tion. Additionally, we used the ES and the SRM to
provide more insight into a potential convergence or
divergence in the level of responsiveness by applying
these two different responsiveness statistics.
However, the number of patients with each mental
disorder may have been too small to draw general
conclusions about whether the preference-based in-
strument is responsive in each mental disorder. None-
theless, we could identify some hints about which
preference-based instrument was more responsive
than the others in each mental disorder using the
same patients. Another limitation was the use of 0.5
standard deviations as the definition of a relevant
change in the anchor. However, we did not find a
valid definition of a relevant change in both anchors.
Finally, we used generic anchors instead of disease-
specific measures to conduct the comparisons of re-
sponsiveness across the mental disorders. Therefore,
additional comparisons of preference-based instru-
ments against other external instruments may be
required.
Sonntag et al. Health and Quality of Life Outcomes  (2015) 13:114 Page 8 of 9Implications for future research
Because many preference-based instruments are available
in the literature, the assessment and comparison of the re-
sponsiveness of these instruments should be extended to
other mental disorders and diseases. Particularly, re-
searchers should compare the responsiveness between
generic (such as the EQ-5D) and disorder-specific
preference-based instruments (e.g., the DEMQOL-U for
patients with dementia [41]). Disorder-specific preference-
based instruments may encompass more specific dimen-
sions that patients feel are relevant for the valuation of
their health status. Moreover, researchers may focus on
the assessment of responsiveness in patients with a deteri-
orated health state.
Conclusion
No preference-based instrument was consistently more
responsive than the others across all mental disorders.
In the patients with schizophrenia, the EQ-5D index-UK
appeared to detect relevant changes in contrast to other
studies. In the patients with affective disorders or alco-
hol addiction, the EQ VAS appeared to be the most re-
sponsive instrument. The responsiveness of the EQ-5D
index-G and the TTO score was low in each mental dis-
order. More responsiveness studies comparing various
preference-based instruments are required.
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